APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anxiety Disorder and Depression Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anxiety Disorder and Depression Treatment Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchAnxiety Disorder and Depression Treatment Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Anxiety Disorder and Depression Treatment Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Anxiety Disorder and Depression Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anxiety Disorder and Depression Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Anxiety Disorder and Depression Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anxiety Disorder and Depression Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anxiety Disorder and Depression Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anxiety Disorder and Depression Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anxiety Disorder and Depression Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anxiety Disorder and Depression Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anxiety Disorder and Depression Treatment market include Lundbeck, AstraZeneca, GSK, Pfizer, Eli Lilly and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anxiety Disorder and Depression Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anxiety Disorder and Depression Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anxiety Disorder and Depression Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anxiety Disorder and Depression Treatment market.

Anxiety Disorder and Depression Treatment Segment by Company

Lundbeck

AstraZeneca

GSK

Pfizer

Eli Lilly

Johnson & Johnson

Anxiety Disorder and Depression Treatment Segment by Type

Drugs

Devices

Anxiety Disorder and Depression Treatment Segment by Application

Hospitals

Mental Healthcare Centers

NGOs

Other

Anxiety Disorder and Depression Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anxiety Disorder and Depression Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anxiety Disorder and Depression Treatment key companies, revenue, market share, and recent developments.

3. To split the Anxiety Disorder and Depression Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anxiety Disorder and Depression Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anxiety Disorder and Depression Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Anxiety Disorder and Depression Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Disorder and Depression Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anxiety Disorder and Depression Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Disorder and Depression Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anxiety Disorder and Depression Treatment industry.

Chapter 3: Detailed analysis of Anxiety Disorder and Depression Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anxiety Disorder and Depression Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anxiety Disorder and Depression Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anxiety Disorder and Depression Treatment Industry Trends Table 2. Anxiety Disorder and Depression Treatment Industry Drivers Table 3. Anxiety Disorder and Depression Treatment Industry Opportunities and Challenges Table 4. Anxiety Disorder and Depression Treatment Industry Restraints Table 5. Global Anxiety Disorder and Depression Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anxiety Disorder and Depression Treatment Revenue Share by Company (2021-2026) Table 7. Global Anxiety Disorder and Depression Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anxiety Disorder and Depression Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Anxiety Disorder and Depression Treatment Company, Product Type & Application Table 10. Global Anxiety Disorder and Depression Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anxiety Disorder and Depression Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drugs Table 15. Significant Companies of Devices Table 16. Global Anxiety Disorder and Depression Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Anxiety Disorder and Depression Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Anxiety Disorder and Depression Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Anxiety Disorder and Depression Treatment Sales Value Share by Type (2021-2026) Table 20. Global Anxiety Disorder and Depression Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Mental Healthcare Centers Table 23. Significant Companies of NGOs Table 24. Significant Companies of Other Table 25. Global Anxiety Disorder and Depression Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anxiety Disorder and Depression Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Anxiety Disorder and Depression Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Anxiety Disorder and Depression Treatment Sales Value Share by Application (2021-2026) Table 29. Global Anxiety Disorder and Depression Treatment Sales Value Share by Application (2027-2032) Table 30. Global Anxiety Disorder and Depression Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Anxiety Disorder and Depression Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Anxiety Disorder and Depression Treatment Sales Value Share by Region (2021-2026) Table 33. Global Anxiety Disorder and Depression Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Anxiety Disorder and Depression Treatment Sales Value Share by Region (2027-2032) Table 35. Global Anxiety Disorder and Depression Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Anxiety Disorder and Depression Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Anxiety Disorder and Depression Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Anxiety Disorder and Depression Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Anxiety Disorder and Depression Treatment Sales Value Market Share by Country (2027-2032) Table 40. Lundbeck Company Information Table 41. Lundbeck Business Overview Table 42. Lundbeck Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Lundbeck Anxiety Disorder and Depression Treatment Product Portfolio Table 44. Lundbeck Recent Development Table 45. AstraZeneca Company Information Table 46. AstraZeneca Business Overview Table 47. AstraZeneca Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. AstraZeneca Anxiety Disorder and Depression Treatment Product Portfolio Table 49. AstraZeneca Recent Development Table 50. GSK Company Information Table 51. GSK Business Overview Table 52. GSK Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. GSK Anxiety Disorder and Depression Treatment Product Portfolio Table 54. GSK Recent Development Table 55. Pfizer Company Information Table 56. Pfizer Business Overview Table 57. Pfizer Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Pfizer Anxiety Disorder and Depression Treatment Product Portfolio Table 59. Pfizer Recent Development Table 60. Eli Lilly Company Information Table 61. Eli Lilly Business Overview Table 62. Eli Lilly Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Eli Lilly Anxiety Disorder and Depression Treatment Product Portfolio Table 64. Eli Lilly Recent Development Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Anxiety Disorder and Depression Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Anxiety Disorder and Depression Treatment Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Research Programs/Design for This Report Table 71. Authors List of This Report Table 72. Secondary Sources Table 73. Primary Sources List of Figures Figure 1. Anxiety Disorder and Depression Treatment Product Image Figure 2. Global Anxiety Disorder and Depression Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anxiety Disorder and Depression Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Anxiety Disorder and Depression Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drugs Image Figure 8. Devices Image Figure 9. Global Anxiety Disorder and Depression Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Anxiety Disorder and Depression Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Anxiety Disorder and Depression Treatment Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Mental Healthcare Centers Image Figure 14. NGOs Image Figure 15. Other Image Figure 16. Global Anxiety Disorder and Depression Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Anxiety Disorder and Depression Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Anxiety Disorder and Depression Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Anxiety Disorder and Depression Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Anxiety Disorder and Depression Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Anxiety Disorder and Depression Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Anxiety Disorder and Depression Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Anxiety Disorder and Depression Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Anxiety Disorder and Depression Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Anxiety Disorder and Depression Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Anxiety Disorder and Depression Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Anxiety Disorder and Depression Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Anxiety Disorder and Depression Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Anxiety Disorder and Depression Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Anxiety Disorder and Depression Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Devices
Applications
  • Hospitals
  • Mental Healthcare Centers
  • NGOs
  • Other
Companies covered
  • Lundbeck
  • AstraZeneca
  • GSK
  • Pfizer
  • Eli Lilly
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anxiety Disorder and Depression Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anxiety Disorder and Depression Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anxiety Disorder and Depression Treatment Market Dynamics
  1. 2.1 Anxiety Disorder and Depression Treatment Industry Trends
  2. 2.2 Anxiety Disorder and Depression Treatment Industry Drivers
  3. 2.3 Anxiety Disorder and Depression Treatment Industry Opportunities and Challenges
  4. 2.4 Anxiety Disorder and Depression Treatment Industry Restraints
3 Anxiety Disorder and Depression Treatment Market by Company
  1. 3.1 Global Anxiety Disorder and Depression Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Anxiety Disorder and Depression Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Anxiety Disorder and Depression Treatment Company Ranking (2024-2026)
  4. 3.4 Global Anxiety Disorder and Depression Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Anxiety Disorder and Depression Treatment Company Product Type and Application
  6. 3.6 Global Anxiety Disorder and Depression Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anxiety Disorder and Depression Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anxiety Disorder and Depression Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anxiety Disorder and Depression Treatment Market by Type
  1. 4.1 Anxiety Disorder and Depression Treatment Type Introduction
  2. 4.1.1 Drugs
  3. 4.1.2 Devices
  4. 4.2 Global Anxiety Disorder and Depression Treatment Sales Value by Type
  5. 4.2.1 Global Anxiety Disorder and Depression Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anxiety Disorder and Depression Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Anxiety Disorder and Depression Treatment Sales Value Share by Type (2021-2032)
5 Anxiety Disorder and Depression Treatment Market by Application
  1. 5.1 Anxiety Disorder and Depression Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Mental Healthcare Centers
  4. 5.1.3 NGOs
  5. 5.1.4 Other
  6. 5.2 Global Anxiety Disorder and Depression Treatment Sales Value by Application
  7. 5.2.1 Global Anxiety Disorder and Depression Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anxiety Disorder and Depression Treatment Sales Value by Application (2021-2032)
  9. 5.2.3 Global Anxiety Disorder and Depression Treatment Sales Value Share by Application (2021-2032)
6 Anxiety Disorder and Depression Treatment Regional Value Analysis
  1. 6.1 Global Anxiety Disorder and Depression Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anxiety Disorder and Depression Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anxiety Disorder and Depression Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anxiety Disorder and Depression Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anxiety Disorder and Depression Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Anxiety Disorder and Depression Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anxiety Disorder and Depression Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Anxiety Disorder and Depression Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anxiety Disorder and Depression Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anxiety Disorder and Depression Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anxiety Disorder and Depression Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Anxiety Disorder and Depression Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anxiety Disorder and Depression Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anxiety Disorder and Depression Treatment Sales Value Share by Country, 2025 VS 2032
7 Anxiety Disorder and Depression Treatment Country-level Value Analysis
  1. 7.1 Global Anxiety Disorder and Depression Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anxiety Disorder and Depression Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anxiety Disorder and Depression Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anxiety Disorder and Depression Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anxiety Disorder and Depression Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anxiety Disorder and Depression Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anxiety Disorder and Depression Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lundbeck
  2. 8.1.1 Lundbeck Company Information
  3. 8.1.2 Lundbeck Business Overview
  4. 8.1.3 Lundbeck Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lundbeck Anxiety Disorder and Depression Treatment Product Portfolio
  6. 8.1.5 Lundbeck Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Anxiety Disorder and Depression Treatment Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Anxiety Disorder and Depression Treatment Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Anxiety Disorder and Depression Treatment Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Eli Lilly
  26. 8.5.1 Eli Lilly Company Information
  27. 8.5.2 Eli Lilly Business Overview
  28. 8.5.3 Eli Lilly Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly Anxiety Disorder and Depression Treatment Product Portfolio
  30. 8.5.5 Eli Lilly Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Anxiety Disorder and Depression Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Anxiety Disorder and Depression Treatment Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst